Selected Publications

• article

  1. Acute Care Events During Systemic Cancer Treatment: Moving From Risk Prediction to Clinical Decision Support Using a Two-Model Approach..  JCO oncology practice.  -. 2026
  2. Comparing Outcomes: In-Person and Telehealth Oncology Visits..  JCO oncology practice.  -. 2026
  3. End-of-Life and Palliative Care Disparities Among American Indians and Alaska Natives with Cancer: A Scoping Review..  The American journal of hospice & palliative care.  -. 2026
  4. Association of Patient-Provider Race/Ethnicity Concordance and Patient-Reported Shared Decision Making Among US Adults: A National Study, 2015-2021..  Journal of general internal medicine.  41:1803-1813. 2025
  5. Real-World Determinants of Olanzapine Prescribing for Antiemetic Prophylaxis in Adults Receiving Highly-Emetogenic Chemotherapy..  Hospital pharmacy.  -. 2025
  6. Shared Decision Making Interventions for Deprescribing in Older Adults With Polypharmacy: A Scoping Review..  Journal of the American Geriatrics Society.  73:3884-3894. 2025
  7. End-of-life care quality for American Indians with cancer..  Journal of the National Cancer Institute.  117:1188-1197. 2025
  8. Intravenous and subcutaneous vedolizumab for moderately to severely active ulcerative colitis in Iran: a model-based cost-effectiveness evaluation..  Expert review of pharmacoeconomics & outcomes research.  25:933-941. 2025
  9. Diabetes medication management recommendations for older adults: A systematic review of the Western Pacific region..  Geriatrics & gerontology international.  25:717-729. 2025
  10. Evaluation of End-of-Life Quality Care Between American Indian and White North Carolina Decedents Diagnosed With Lung Cancer, 2003-2020..  JCO oncology practice.  21:1344-1353. 2025
  11. Cost-Effectiveness Analysis of Pharmacogenomics-Guided Versus Standard Dosing of Warfarin in Patients with Mechanical Prosthetic Heart Valve..  Iranian journal of pharmaceutical research : IJPR.  23:-. 2024
  12. Cost-Effectiveness of Ibrutinib as First-line Treatment for Older Patients With Chronic Lymphocytic Leukemia in Iran..  Value in health regional issues.  93-100. 2023
  13. A cost-effectiveness analysis of linagliptin add-on to insulin treatment for patients with type 2 diabetes mellitus and chronic kidney disease in Iran..  Journal of diabetes and metabolic disorders.  22:1263-1271. 2023
  14. Upfront DPYD Genotype-Guided Treatment for Fluoropyrimidine-Based Chemotherapy in Advanced and Metastatic Colorectal Cancer: A Cost-Effectiveness Analysis..  Value in health regional issues.  71-80. 2023